Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3832) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 januari 2000News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 januari 2000Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 januari 2000Press releaseHumanRare diseases Committee for veterinary medicinal products: 51st meeting 13 januari 2000Press releaseVeterinary Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 december 1999News Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 december 1999Press release Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 december 1999News Committee for veterinary medicinal products: 50th meeting 9 december 1999Press releaseVeterinary Twenty-fourth Meeting of the Management Board 2 december 1999Press releaseCorporate Committee for Proprietary Medicinal Products (CPMP) 54th plenary meeting 22 november 1999Press release 1 … 366 367 368 369 370 Page 370 of 384 371 372 373 374 … 384
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 januari 2000News
Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 januari 2000Press release
3rd meeting of the Committee for Orphan Medicinal Products 19 januari 2000Press releaseHumanRare diseases
Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 december 1999News
Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 december 1999Press release
Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 december 1999News
Committee for Proprietary Medicinal Products (CPMP) 54th plenary meeting 22 november 1999Press release
